• Interaction Score: 53.16

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Indication/Tumor Type acute myeloid leukemia
    Response Type sensitive
    Approval Status FDA approved

  • Interaction Score: 4.96

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Indication/Tumor Type acute myeloid leukemia
    Response Type predicted – sensitive
    Approval Status Phase II

  • Interaction Score: 1.64

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Indication/Tumor Type intrahepatic cholangiocarcinoma
    Response Type sensitive
    Approval Status Preclinical

    PMIDs:
    27231123


    Sources:
    JAX-CKB

  • Interaction Score: 1.18

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    combination therapy Enasidenib + Quizartinib
    Indication/Tumor Type acute myeloid leukemia
    Response Type predicted – sensitive

    PMIDs:
    None found


    Sources:
    JAX-CKB

  • Interaction Score: 0.71

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    28148839


    Sources:
    CIViC

  • Interaction Score: 0.43

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Indication/Tumor Type intrahepatic cholangiocarcinoma
    Response Type sensitive
    Approval Status Preclinical

    PMIDs:
    27231123


    Sources:
    JAX-CKB CGI